(Q33794479)

29 July 2017

1 reference

title

Effects of H1 antihistamines on animal models of QTc prolongation (English)

1 reference

29 July 2017

1 reference

J Gras

1

1 reference

29 July 2017

J Llenas

series ordinal

2

1 reference

29 July 2017

publication date

1 January 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

21 Suppl 1

1 reference

29 July 2017

page(s)

39-44; discussion 81-7

1 reference

Mechanism of the cardiotoxic actions of terfenadine

29 July 2017

cites work

1 reference

12 December 2020

Comparative effects of nonsedating histamine H1 receptor antagonists, ebastine and terfenadine, on human Kv1.5 channels

1 reference

12 December 2020

Cardiac electrophysiological actions of the histamine H1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine

1 reference

12 December 2020

From the Food and Drug Administration

1 reference

12 December 2020

Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol.

1 reference

12 December 2020

Experimental models of torsades de pointes

1 reference

12 December 2020

Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy

1 reference

12 December 2020

Determination of terfenadine and terfenadine acid metabolite in plasma using solid-phase extraction and high-performance liquid chromatography with fluorescence detection

1 reference

12 December 2020

Some observations on the cardiotoxic and drug interaction profiles of second generation antihistamines as measured in the guinea pig

1 reference

12 December 2020

Cardiotoxic and drug interaction profile of the second generation antihistamines ebastine and terfenadine in an experimental animal model of torsade de pointes

1 reference

12 December 2020

Regulation of potassium channels by nonsedating antihistamines

1 reference

12 December 2020

Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin

1 reference

12 December 2020

Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders

1 reference

12 December 2020

Effects of terfenadine and its metabolites on a delayed rectifier K+ channel cloned from human heart

1 reference

12 December 2020

The role of ketoconazole in the QTc interval prolonging effects of H1-antihistamines in a guinea-pig model of arrhythmogenicity

1 reference

12 December 2020

Interactions of the nonsedating antihistamine loratadine with a Kv1.5-type potassium channel cloned from human heart

1 reference

12 December 2020

Electrophysiological and arrhythmogenic effects of the histamine type 1-receptor antagonist astemizole on rabbit Purkinje fibers: clinical relevance

1 reference

12 December 2020

Torsades de pointes occurring in association with terfenadine use

1 reference

12 December 2020

Oxidation of the antihistaminic drug terfenadine in human liver microsomes. Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation

1 reference

12 December 2020

Terfenadine alters action potentials in isolated canine Purkinje fibers more than acrivastine

1 reference

12 December 2020

QTU-prolongation and torsades de pointes induced by putative class III antiarrhythmic agents in the rabbit: etiology and interventions.

1 reference

12 December 2020

Blockade of multiple human cardiac potassium currents by the antihistamine terfenadine: possible mechanism for terfenadine-associated cardiotoxicity

1 reference

12 December 2020

Torsade de pointes. Mechanisms and management.

1 reference

12 December 2020

Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences

1 reference

12 December 2020

10.2165/00002018-199921001-00006

Identifiers

DOI

0 references

Dimensions Publication ID

1009678295

0 references

1 reference